Facing an acute shortage of Covid-19 vaccines, the Centre is likely to grant indemnity against legal proceedings to foreign vaccine makers such as Moderna and Pfizer before the rollout of their vaccines in India. Earlier, India had been at loggerheads with Pfizer over the pharmaceutical company seeking an 'indemnity clause' which would make it immune to any claims linked to the use of its Covid-19 vaccine. India has not given any vaccine manufacturer indemnity so far against the costs of compensation for side-effects related to their vaccines. Watch what discount has been given at Moderna-Pfizer vaccine.